Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

FHS
June 29, 2023
5:11 am

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT – Biotech Investments

, 04/24/2024 / 06:00, EST/EDT – EQS Newswire – Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange,

April 25, 2024

SARS-CoV-2 spike protein could be speeding up Alzheimer’s and other brain diseases, says new study

Swedish researchers find that SARS-CoV-2’s spike protein amyloids can accelerate the formation of harmful protein aggregates related to neurodegenerative diseases like Creutzfeldt-Jakob and Alzheimer’s. The

September 5, 2023

How immune cells shape our earliest breaths

Study profiles the development of immune cells in human lungs during embryonic and fetal stages, revealing their influence on epithelial cell fate and lung development.

January 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.